Related by context. All words. (Click for frequent words.) 70 sequential dose escalation 68 blinded randomized placebo controlled 67 multicenter Phase III 66 efavirenz EFV 66 multicentre randomized 66 prospective randomized multicenter 65 relapsed MM 65 ascending dose 65 Tarceva TM 65 active comparator 65 oral rivaroxaban 65 orally inhaled 65 double blinded randomized 64 pan histone deacetylase 64 ritonavir boosted 64 oral ribavirin 64 multicenter multinational 64 double blinded placebo 64 pharmacokinetics PK 64 multicenter randomized placebo controlled 64 Phase IIIb 64 Ziprasidone 64 Mg Uk 64 multidose 64 phase IIIb 64 multicenter randomized 64 galiximab 64 randomized multicenter 64 visilizumab 64 MAGE A3 ASCI 63 CIMZIA TM certolizumab pegol 63 multicenter Phase II 63 pharmacodynamic profile 63 Teriflunomide 63 serotonin norepinephrine reuptake inhibitor 63 generation purine nucleoside 63 Serevent salmeterol 63 TMC# C# 63 pharmacologically active isomer 63 prospective multicenter randomized 63 unfractionated heparin UFH 63 INSPIRE Trial Phase III 63 aspirin clopidogrel 63 cisplatin gemcitabine 63 cromolyn sodium 63 albiglutide 63 randomized controlled multicenter 63 docetaxel Taxotere R 63 9mg 63 topiramate Topamax 63 Dabigatran etexilate 63 8mg/kg 62 PEGINTRON TM 62 investigational oral 62 Phase III multicenter 62 tolerability pharmacokinetics 62 phase Ib 62 placebo controlled clinical 62 risedronate sodium tablets 62 fenofibric acid 62 antidepressants fluoxetine 62 irbesartan 62 dose escalation trial 62 Mycophenolate Mofetil 62 EDEMA3 62 Sanofi Pasteur Fluzone 62 pregabalin Lyrica 62 Aflibercept 62 interferon beta 1b 62 biologic DMARD 62 BRIM2 62 NATRECOR ® 62 controlled multicenter 62 AVOREN 62 APEX PD 62 Initiated Phase 62 nab paclitaxel 62 randomized multicenter trial 62 Xeloda ® 62 dose escalation clinical 62 metastatic hormone refractory 62 BENICAR HCT 62 subcutaneously administered 62 rosuvastatin Crestor 62 Phase #/#a 62 Navelbine ® 62 azilsartan medoxomil 61 DU #b 61 oral deforolimus 61 erlotinib Tarceva ® 61 RezularTM 61 DEB# 61 dose dose escalation 61 evaluating tivozanib 61 #mg #mg [001] 61 label dose escalation 61 EFFEXOR XR 61 ZOLINZA 61 Recurrent Glioblastoma 61 1mg 2mg 61 registrational Phase 61 ZACTIMA 61 RG# ITMN 61 nasally administered 61 Mg Usa 61 phase IIb clinical 61 Phase Ib II 61 Phase 1b trial 61 label multicenter Phase 61 channel blocker amlodipine 61 evaluating satraplatin 61 aflibercept VEGF Trap 61 interferon gamma 1b 61 Darusentan 61 bolus dose 61 budesonide pMDI 61 dose escalation Phase 61 inhalations twice 61 ramipril Altace 61 vapreotide acetate 61 INVEGA SUSTENNA 61 gadobutrol 61 ritonavir boosted atazanavir 61 sulfonylurea metformin 61 teriflunomide 61 Pemetrexed 61 administered subcutaneously 61 Adalimumab 61 raloxifene Evista 61 AIR CF1 61 certolizumab 61 NS5B polymerase 61 SCH # 61 alendronate Fosamax 61 maximally tolerated dose 61 prospective multicenter 61 ACTEMRA TM 61 inhaled corticosteroid ICS 61 investigational protease inhibitor 61 Catapres 61 docetaxel Taxotere ® 61 sorafenib Nexavar 61 prospectively randomized 61 Warner Chilcott Actonel 61 YONDELIS 61 atazanavir ritonavir 61 randomized Phase III 61 multicenter clinical 61 placebo controlled randomized 61 Phase IIIb clinical 61 Panzem R NCD 61 ongoing Phase 1b 61 arsenic trioxide injection 61 glulisine 61 Zemplar Capsules 61 acyclovir Lauriad R 61 protease inhibitor PI 61 Phase III randomized controlled 61 Bayer HealthCare Onyx Pharmaceuticals 61 candesartan cilexetil 61 non nucleoside inhibitor 61 orally disintegrating 60 thorough QT 60 escitalopram oxalate 60 TBC# 60 dihydroergotamine DHE 60 evaluating Actimmune 60 pioglitazone HCl 60 long acting muscarinic 60 randomized controlled Phase 60 Prospective Randomized 60 phase IIb trial 60 reslizumab 60 SPRYCEL ® 60 Betaferon ® 60 CHAMPION PCI 60 RELOVAIR ™ 60 atorvastatin Lipitor 60 phase III isavuconazole 60 divalproex sodium 60 PrevOnco ™ 60 #mg #mg #mg #mg [002] 60 Tanespimycin 60 tenofovir Viread 60 REMINYL ® 60 Phase 2a trial 60 alpha blocker 60 epoetin alpha 60 sorafenib tablets 60 QD dosing 60 nucleoside analog 60 insulin aspart 60 miconazole Lauriad ® 60 subcutaneous dose 60 CANCIDAS 60 ORENCIA ® 60 capsules USP 60 oral dual endothelin 60 latrepirdine 60 dexpramipexole 60 Double Blind Randomized 60 controlled multicenter Phase 60 phase IIb 60 multicentre randomized double 60 R bisoprolol Euthyrox 60 #mg/#mg 60 5mg #mg 60 sitaxsentan 60 brand ciclesonide HFA 60 phase IIa clinical 60 ToGA 60 PI3K/Akt pathway inhibitor 60 fluticasone furoate 60 Emtriva Viread 60 metformin sulfonylurea 60 pharmacodynamic properties 60 randomized blinded 60 safety tolerability pharmacokinetics 60 randomized multicentre 60 CTA# Injection 60 TNF alpha inhibitor 60 metreleptin 60 forodesine 60 continuous intravenous infusion 60 pharmacokinetic PK study 60 Ropinirole 60 Degarelix 60 alefacept 60 safety tolerability pharmacokinetic 60 FOLFOX6 chemotherapy regimen 60 humanized therapeutic 60 sertraline Zoloft 60 platelet inhibitor 60 riociguat 60 ATACAND 60 GSK# [001] 60 vinca alkaloid 60 formoterol fumarate 60 IMiDs ® 60 pegylated interferon alfa 2a 60 ® lenalidomide 60 Ozarelix 60 liposomal formulation 60 sulfonylurea glimepiride 60 pharmacodynamic effects 60 symptomatic BPH 60 AZILECT R 60 REVIVE Diabetes 60 atorvastatin #mg 60 multicenter randomized double 60 Targretin capsules 60 #mg #mg #mg [003] 60 viral kinetic 60 blinded placebo controlled 60 cathepsin K inhibitor 60 pharmacodynamics PD 60 ADP receptor antagonist 60 trastuzumab emtansine T DM1 60 CIMZIA TM 60 6mg 60 treatment naive genotype 60 beta 1a 60 prednisone CHOP 60 microgram kg 60 peginterferon alfa 2b 60 lamotrigine Lamictal 60 TO AVOID PREGNANCY WHILE 60 Randomized Phase II 60 prospective randomized placebo 60 Lanoxin 60 intravenous dosing 60 label multicenter 60 abacavir lamivudine 59 adefovir dipivoxil 59 multicenter placebo controlled 59 Paxil paroxetine 59 ritonavir boosted lopinavir 59 Trandolapril 59 Vidaza azacitidine 59 nitroprusside 59 sorafenib Nexavar ® 59 dosed orally 59 sitagliptin Januvia 59 Multiple Ascending Dose 59 subcutaneous SC 59 Eszopiclone 59 MEVACOR 59 5 fluorouracil leucovorin 59 docetaxel chemotherapy 59 Xeloda capecitabine 59 clomipramine 59 Coadministration 59 ribavirin Copegus 59 LAB CGRP 59 Humira adalimumab 59 glycoprotein IIb IIIa inhibitor 59 pegylated interferon alpha 59 BENICAR 59 Lexapro Effexor Serzone 59 nonrandomized 59 placebo controlled Phase 59 Amrubicin 59 APTIVUS 59 dasatinib Sprycel ® 59 aliskiren amlodipine 59 rFSH 59 landmark ATHENA 59 LEVAQUIN ® 59 risperidone Risperdal 59 weekly subcutaneous injections 59 combines bupropion 59 desvenlafaxine succinate 59 subcutaneous formulation 59 lamivudine zidovudine 59 ADVANCE PD 59 IV bolus 59 RSD# oral 59 blind multicenter 59 crizotinib PF # 59 Anturol TM 59 pegylated liposomal doxorubicin 59 Kinesin Spindle Protein KSP 59 HMG CoA reductase inhibitors 59 cholestyramine 59 pioglitazone hydrochloride 59 Mipomersen 59 Dapagliflozin 59 phase Ib clinical 59 orally administered inhibitor 59 evaluating Vectibix 59 synthetic progestin 59 intravenously administered 59 abacavir Ziagen 59 LPV r 59 elotuzumab 59 EPIVIR 59 angiotensin receptor blocker ARB 59 statin simvastatin 59 evaluating Xcytrin 59 PD LID 59 GOUT 59 fosbretabulin 59 LymphoStat B TM 59 Phase III Clinical Trial 59 ancrod 59 goserelin 59 ZYBRESTAT fosbretabulin 59 bupropion SR 59 Traficet EN 59 prucalopride 59 pravastatin Pravachol 59 mycophenolate mofetil MMF 59 intranasal formulation 59 vidofludimus 59 paclitaxel poliglumex 59 EOquin TM 59 Dual Opioid 59 AndroGel ® 59 intravenous RSD# 59 Darunavir 59 dose escalation phase 59 Randomized Phase 59 prochlorperazine 59 ROCKET AF 59 ergot derivatives 59 PREZISTA r 59 NSABP B 59 adenosine injection 59 masked placebo controlled 59 dosing cohort 59 clozapine Clozaril 59 pertuzumab 59 DLTs 59 de novo kidney transplant 59 GW# [003] 59 Azathioprine 59 CEL SCI Phase III 59 PROTEGE 59 Phase IIb IIIa 59 assessing T DM1 59 EmbraceAC 59 Dose Ranging Study 59 memantine HCl 59 metaglidasen 59 oral renin inhibitor 59 5 FU leucovorin 59 peginterferon alpha 2a 59 prospective observational 59 selective phosphodiesterase 59 AIR CF3 59 pegylated interferon alpha 2a 59 neratinib 59 non valvular atrial 59 metastatic malignant 59 methylnaltrexone bromide 59 KAPIDEX 59 mometasone 59 bolus injection 59 AEGR 59 Ixempra 59 SUSTENNA TM 59 Pharmacokinetics PK 59 fluoxetine HCl 59 alfa 2a 59 Empatic ™ 59 Randomized Double blind 59 beclomethasone dipropionate 59 Pharmacokinetic Study 59 leukotriene receptor antagonist 59 clinical trials Archexin 59 Initiate Phase 59 #mg doses [002] 59 PEGASYS ® 59 gliclazide 59 R Saizen R 59 colesevelam HCl 59 multicenter Phase 59 placebo controlled Phase III 59 Toremifene 59 plus COPEGUS 59 dose regimens 59 Phase III placebo controlled 59 PSMA ADC 59 Phase IIIb study 58 Betaferon R 58 refractory chronic lymphocytic 58 plus prednisone 58 mg qd 58 bortezomib Velcade R 58 subcutaneous enoxaparin 58 urate lowering 58 HGS# 58 Intravitreal 58 multinational multicenter randomized 58 sunitinib malate 58 doxepin HCl 58 humanized interleukin 6 58 receptor tyrosine kinase inhibitor 58 humanised monoclonal antibody 58 ABC/3TC 58 metformin HCl 58 COPEGUS therapy 58 6R BH4 58 RLAI 58 interferon alfa 2b 58 beta2 agonist 58 ASTEROID 58 Capesaris 58 PRISTIQ 58 doxorubicin cyclophosphamide 58 paclitaxel Taxol R 58 UCB Keppra 58 intravenous bolus 58 PTH1 58 fistulizing Crohn disease 58 darunavir ritonavir 58 chemotherapy FOLFOX 58 prospective randomized controlled 58 Androxal TM 58 bendamustine 58 RoACTEMRA 58 INFERGEN 58 Phase #b/#a trial 58 saline placebo 58 flutamide 58 Safinamide 58 intermittent dosing 58 CHOP chemotherapy 58 Humalog ® 58 VIRAMUNE XR 58 MAO inhibitor 58 antiplatelet agent 58 APTIVUS r 58 Folfox 58 novel VDA molecule 58 label dose titration 58 Carotid Revascularization Endarterectomy vs. 58 rizatriptan 58 Ramelteon 58 Sapacitabine 58 IMiDs 58 cediranib 58 oral ridaforolimus 58 Acute Ischemic Stroke 58 Phase III randomized 58 alvespimycin 58 antiepileptics 58 human Chorionic Gonadotropin 58 CIMZIA ™ 58 comparing XIENCE V 58 aplindore 58 yearly subcutaneous injections 58 Oral NKTR 58 JAK inhibitor 58 valerate 58 PRADAXA 58 Pertuzumab 58 GetGoal Phase III 58 cyclophosphamide doxorubicin vincristine 58 JANUVIA 58 FEMALES SHOULD BE ADVISED 58 virus HCV protease inhibitor 58 PHX# 58 equi analgesic doses 58 limiting toxicity DLT 58 rabeprazole 58 CYT# QbG# 58 Hydrochlorothiazide Tablets 58 tenofovir emtricitabine 58 Clolar ® 58 GLP1 agonist 58 Platinol ® cisplatin 58 melphalan prednisone 58 rhIGF-I/rhIGFBP-3 58 metastatic GIST 58 proton pump inhibitor PPI 58 metastatic androgen independent 58 Glycopyrrolate 58 Double Blind Placebo 58 q8h 58 Prozac Paxil Zoloft Celexa 58 Navelbine 58 label multicenter randomized 58 Phase III confirmatory 58 EQUIP OB 58 Hormone Refractory Prostate Cancer 58 Camptosar ® 58 daily subcutaneous injections 58 oral transmucosal 58 MYDICAR ® 58 R ferumoxytol Injection 58 Prograf ® 58 Taxotere R 58 Roflumilast 58 salmeterol fluticasone 58 ® pioglitazone HCl 58 Clonicel 58 levalbuterol 58 confirmatory clinical 58 ibandronate 58 High Dose quadruples 58 GnRH agonist 58 ZD# [001] 58 oral alendronate 58 ascending doses 58 oral antiviral 58 valsartan amlodipine 58 Ophena TM 58 Zolpimist ™ 58 Kuvan sapropterin dihydrochloride 58 Quinamed 58 heFH 58 intranasally administered 58 Phase 2a clinical 58 amprenavir 58 conivaptan 58 IMiDs R 58 olmesartan 58 headache nasopharyngitis 58 placebo controlled dose escalation 58 glatiramer acetate 58 postmenopausal osteoporotic women 58 TYGACIL 58 #mg/day [001] 58 EOquin TM phase 58 GAMMAGARD 58 immunomodulator 58 LEXIVA r 58 Dapoxetine 58 Phase IIb Trial 58 samalizumab 58 pharmacokinetic characteristics 58 either acutely decompensated 58 ziprasidone Geodon 58 mTOR inhibitor 58 mertansine 58 highly selective endothelin 58 CERVARIX 58 DIRECT Trial 58 #mg/m# [001] 58 Gemzar gemcitabine 58 Valcyte tablets 58 zonisamide SR 58 HCl capsules 58 subcutaneous doses 58 phase IIb study 58 R# #mg BID 58 demonstrated antitumor activity 58 insulin lispro 58 volociximab 58 Aciphex R 58 Bosutinib 58 oral prodrug 58 ACCOMPLISH 58 biphasic insulin aspart 58 desvenlafaxine 58 corticosteroid dexamethasone 58 PEGylated interferon 58 Meridia sibutramine 58 multicenter randomized controlled 58 dirucotide MBP# 58 designated HVTN 58 zoledronic acid Reclast 57 cetuximab Erbitux R 57 plus dexamethasone 57 bevacizumab Avastin ® 57 BMS # 57 multicentre prospective 57 ELONVA 57 Naive Patients 57 Controlled Trial 57 HCD# [002] 57 somatostatin analog 57 placebo controlled 57 #mg QD [002] 57 HCV NS5B polymerase 57 alfuzosin 57 ALN VSP Phase 57 oral chemotherapeutic agent 57 zidovudine lamivudine 57 LEVADEX ™ 57 By JENNIFER LEARN 57 GATTEX ® 57 Deforolimus 57 adjunctive ABILIFY 57 Peg IFN 57 Omacetaxine mepesuccinate 57 phase 2a 57 sapacitabine CYC# 57 Dabigatran 57 cetrorelix pamoate 57 mixed hyperlipidemia 57 NovoLog ® Mix 57 AAG geldanamycin analog 57 prednisone prednisolone plus 57 coadministration 57 Laquinimod 57 tricyclic antidepressant 57 primary hypercholesterolemia 57 Rigel R# 57 EQUETRO 57 Phase 1b dose escalation 57 Daclizumab 57 orally dosed 57 Placebo Controlled 57 IL# PE#QQR 57 regorafenib 57 Phase 1b clinical 57 Antiarrhythmic 57 infliximab monotherapy 57 retrospective observational study 57 pharmacodynamic profiles 57 clevidipine 57 Glatiramer acetate 57 R metformin Concor 57 cilengitide 57 Peginterferon 57 Vidaza R 57 Decadron 57 Novartis Trileptal 57 nucleotide analogue 57 low dose cytarabine 57 BYSTOLIC 57 venlafaxine XR 57 fluticasone propionate 57 balsalazide disodium 57 lumiliximab 57 Dasatinib 57 fluticasone salmeterol 57 intravesical infusion therapy 57 #mg capsules [001] 57 FUSILEV enhances 57 SUTENT ® 57 Vytorin combines 57 vasomotor symptoms associated 57 plus prednisone prednisolone 57 2 methoxyestradiol 57 PANVAC VF 57 Pyridorin 57 trials RCTs 57 Sotret 57 mitoxantrone plus 57 efalizumab 57 prescription laxative 57 ug kg 57 pomalidomide 57 tramiprosate Alzhemed TM 57 Methylnaltrexone 57 mapatumumab 57 darunavir r 57 norethindrone 57 mg hydrochlorothiazide 57 Phase 1b clinical trials 57 PegIntron 57 PRT# 57 dose escalation study 57 bevirimat Study 57 phase IIa 57 Risperidone Oral Solution 57 zolmitriptan 57 Ovitrelle R Serostim 57 treatment naïve genotype 57 CINQUIL 57 Hycamtin ® 57 Vernakalant 57 GATTEX ™ 57 Vertex hepatitis C 57 Omnitarg 57 Temsirolimus 57 Diamyd R 57 RANK Ligand inhibitor 57 Tyrima 57 lenalidomide dexamethasone 57 Atripla combines 57 salmeterol inhalation powder 57 mg administered orally 57 fluvastatin 57 multicentre randomized controlled 57 Phase 2b clinical trials 57 VEGFR2 inhibitor 57 MIRAPEX ER 57 AZILECT 57 Meets Primary Endpoint 57 R memantine HCl 57 Phase 2b study 57 flecainide 57 eplerenone 57 Elitek 57 terfenadine 57 glycopyrrolate 57 lispro 57 RE LY 57 dyskinesia PD LID 57 II Clinical Trial 57 donepezil Aricept 57 anthracycline taxane 57 ORMD 57 fostamatinib 57 multicentre 57 antidepressant trazodone 57 Glypromate 57 Femara letrozole 57 Serious adverse reactions 57 lomitapide 57 biliary tract cancer 57 Phase Ib clinical 57 phosphodiesterase inhibitor 57 via intradermal injections 57 metastatic HRPC 57 HCV SPRINT 57 H2 blocker 57 selective estrogen receptor modulator 57 IMPACT DCM 57 dalteparin 57 Dacogen decitabine 57 Vincristine 57 indacaterol 57 paroxetine Paxil 57 IMiDs ® compound 57 lorcaserin Phase 57 pimecrolimus cream 57 opioid narcotic 57 Pazopanib 57 EURIDIS 57 CLARITY TIMI 57 Elagolix 57 Pivotal Trial 57 3mg/kg 57 stavudine lamivudine 57 Bystolic nebivolol 57 midstage clinical 57 approved incretin mimetic 57 mcg doses 57 Randomized Double Blind 57 mild hepatic impairment 57 4mg/kg 57 analgesic efficacy 57 cancer neuroendocrine tumor 57 ferumoxytol Injection 57 Afatinib 57 Randomized controlled 57 Valsartan 57 CNS depressant 57 containing abacavir 57 Leuprolide 57 randomized placebo controlled 57 mg RDEA# 57 LIALDA 57 pegylated interferons 57 #.#mg 1mg 57 IMPDH inhibitor 57 TDF FTC 57 lopinavir r 57 VICTOR E1 57 ReoPro 57 ciprofloxacin hydrochloride 57 danazol 57 CYT# potent vascular disrupting 57 PEG IFN 57 Pegasys ® 57 Phase #b/#a clinical 57 pegylated interferon alfa 57 mg subcutaneous 57 Viagra Soft Cialis Soft 57 adalimumab Humira 57 MEND CABG 57 Rosuvastatin 57 Crestor rosuvastatin 57 tolerated dose MTD 57 PPAR gamma agonist 57 #.#mg dose 57 LUX Lung 57 EMBEDA TM 57 SPIRIT FIRST 57 mGluR5 negative 57 CYPHER R Sirolimus eluting 57 receiving INTRON 57 hypoxia activated prodrug 57 atazanavir Reyataz 57 Allovectin 7 ® 57 tetracycline antibiotic 57 anastrazole 57 MIRCERA 57 orally inhaled migraine 57 oral levofloxacin 57 #.#g/day 57 Fondaparinux 57 BoNTA 57 liposome injection 57 Phase Ib study 57 neutropenic sepsis 57 Blind Placebo Controlled Trial 57 boosted protease inhibitor 57 BZA CE 57 gemcitabine Gemzar 57 tipifarnib 57 Ophena 57 μg dose 57 nicardipine 57 evaluating mipomersen 57 BR.# 57 R sorafenib tablets 57 investigational integrase inhibitor 57 basiliximab 57 SYNERGY Stent 57 estramustine 57 tacrolimus ointment 57 ALN HPN 56 Altera Nebulizer System 56 ACE inhibitor benazepril 56 nasal calcitonin product 56 Tekamlo 56 LymphoStat B belimumab 56 Neulasta R 56 brivaracetam 56 AZOR 56 Heterozygous Familial Hypercholesterolemia 56 Afinitor everolimus 56 DermaVir Patch 56 PEG INTRON R 56 venlafaxine ER 56 multicenter randomized Phase 56 RE LY ® 56 Silodosin 56 CLARITY study 56 mycophenolate mofetil 56 See CLINICAL PHARMACOLOGY 56 injectable diclofenac 56 ULTRAM ER 56 Celebrex celecoxib 56 multicenter randomized Phase III 56 Focalin XR R 56 FOSRENOL ® 56 rosuvastatin #mg 56 blind randomized controlled 56 Tegretol carbamazepine 56 insulin detemir 56 Plavix clopidogrel bisulfate 56 Gadavist 56 4mg 56 intravitreal insert 56 antiangiogenic agent 56 lixisenatide 56 oxybutynin chloride 56 Phase IIb clinical 56 PPI omeprazole 56 partner ECR Pharmaceuticals 56 Study Evaluating 56 8mg 56 efficacy tolerability 56 Adenoscan R 56 Engerix B 56 PROMUS Element Stent 56 Multicenter 56 dexamethasone Decadron 56 CATIE AD 56 INTELENCE 56 inhaled fluticasone 56 WX UK1 56 nonmetastatic prostate cancer 56 epirubicin cyclophosphamide 56 HuMax CD4 56 migraine prophylaxis 56 single ascending dose 56 ceftazidime 56 PRE SURGE 56 multicenter prospective 56 monoamine oxidase inhibitor 56 Carbidopa Levodopa 56 polymerase inhibitor 56 Pivotal Phase III 56 TEMODAL 56 Metadate 56 Motesanib 56 Placebo controlled 56 FASLODEX 56 CIMZIA R 56 INVEGA ® 56 risperidone olanzapine 56 Matrix Phase 2b 56 factorial design 56 #mg/m# [002] 56 basal insulin analogue 56 CK # administered 56 rheumatoid arthritis psoriatic arthritis 56 placebo controlled studies 56 alpha 2a 56 Annamycin 56 bortezomib Velcade 56 NO# [002] 56 REVLIMID lenalidomide 56 potentially hepatotoxic 56 Crofelemer budesonide foam 56 relapsed myeloma 56 relapsed refractory multiple myeloma 56 PDX pralatrexate 56 Prostate AdenoCarcinoma Treatment 56 Zenvia Phase III 56 capecitabine Xeloda 56 PEGylated interferon beta 1a 56 IIIa inhibitor 56 thalidomide Thalomid 56 Alzhemed TM 56 investigational antiplatelet agent 56 automated radiopharmaceutical distribution 56 recurrent glioblastoma multiforme 56 randomized crossover 56 nilotinib Tasigna ® 56 pharmacokinetic PK 56 chemotherapeutic regimen 56 REGN# 56 isosorbide mononitrate 56 #I TM# 56 randomized #:#:# 56 ezetimibe Zetia 56 μg d 56 Lopid 56 intravenous IV infusion 56 daily Infergen 56 mcg BID 56 Phase IIb clinical trials 56 tasocitinib 56 Xelox 56 Hsp# Inhibitor 56 TLK# 56 Announces Tentative Approval 56 Fixed Dose 56 PRECiSE 56 Phase III ADT 56 Phase IIa trial 56 Velcade bortezomib 56 controlled dose escalation 56 morphine fentanyl 56 bepotastine besilate nasal spray 56 Gabapentin GR 56 dose intramuscular 56 prospective multicentre 56 Cotavance 56 amphotericin B 56 Val HeFT 56 alpha 2b 56 ARCOXIA 56 PrevOnco 56 COLAZAL R 56 injected subcutaneously 56 budesonide foam 56 sildenafil citrate Viagra 56 indinavir Crixivan 56 Nexavar sorafenib 56 posaconazole 56 pitavastatin 56 Arranon 56 randomized discontinuation 56 #mg #mg #mg [002] 56 XL# XL# XL# 56 Phase 1b 56 balsalazide tablet 56 icatibant 56 mg m²